ROR2 is up-regulated in a lot of human tumors including osteosarcoma, melanoma, renal cell carcinoma, prostate carcinoma, colorectal cancer, squamous cell carcinomas of the head and neck, stromal tumors, and breast cancers [19–26]. Here, ROR2 is linked to breast cancer.